Precision BioSciences, Inc. (DTIL)
After hours:
| Previous close | 10.17 |
| Open | 10.19 |
| Bid | 0.00 x 0 |
| Ask | 0.00 x 0 |
| Day's range | 9.99 - 10.24 |
| 52-week range | 8.25 - 19.43 |
| Volume | |
| Avg. volume | 38,853 |
| Market cap | 69.949M |
| Beta (5Y monthly) | 1.73 |
| PE ratio (TTM) | N/A |
| EPS (TTM) | -5.61 |
| Earnings date | 02 Aug 2024 - 06 Aug 2024 |
| Forward dividend & yield | N/A (N/A) |
| Ex-dividend date | N/A |
| 1y target est | 33.00 |
Business WirePrecision BioSciences to Present at the Upcoming JonesTrading Healthcare Seaside Summit
DURHAM, N.C., July 08, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies, today announced that the company will present at the upcoming JonesTrading Healthcare Seaside Summit being held July 14-16, 2024 in San Diego, California.
Business WirePrecision BioSciences Announces its Addition to the Russell Microcap® Index
DURHAM, N.C., July 01, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, today announced its addition to the Russell Microcap® Index. Precision’s inclusion in the index follows the conclusion of the 2024 Russell indexes annual reconstitution, which became effective after the close of U.S. mark
Business WirePrecision BioSciences Announces Presentation at UMDF Mitochondrial Medicine 2024 Supporting Advancement of PBGENE-PMM Program Towards IND and/or CTA in 2025
DURHAM, N.C., June 27, 2024--Precision BioSciences, Inc. (Nasdaq: DTIL), an advanced gene editing company utilizing its novel proprietary ARCUS® platform to develop in vivo gene editing therapies for sophisticated gene edits, including gene elimination, insertion, and excision, is presenting data today at the United Mitochondrial Disease Foundation’s (UMDF) Mitochondrial Medicine 2024 Conference being held in Cleveland, Ohio from June 26-29, 2024.
